Everlive Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.00 M
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 150.48%
- Profit Growth 105.26%
- Ebitda 119.71%
- Net Worth 0.38%
- Total Assets 30.99%
About Everlive Pharma
Everlive Pharma Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 June 2018 (Six years and seven months 27 days old ). Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Jewelry & Fashion Accessories Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Anish Akbar, Sherin Ameer, and Mohammed Begam serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33302TN2018PTC123099
-
Company No.
123099
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Jun 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Everlive Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anish Akbar
|
Managing Director | 07-Jun-2018 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sherin Ameer | Additional Director | 10-Jul-2024 | Current |
| Mohammed Begam | Additional Director | 10-Jul-2024 | Current |
Financial Performance of Everlive Pharma.
Everlive Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 150.48% increase. The company also saw a substantial improvement in profitability, with a 105.26% increase in profit. The company's net worth moved up by a moderate rise of 0.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Everlive Pharma?
Unlock access to Everlive Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
New Viswabharathy Drug Lines Private LimitedAnish Akbar is a mutual person
-
Medicotrade Distributor Private Limited
Anish Akbar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Everlive Pharma?
Unlock and access historical data on people associated with Everlive Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Everlive Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Everlive Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
